SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-25-001743
Filing Date
2025-01-10
Accepted
2025-01-10 16:45:26
Documents
43
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 544108
2 ex31-1.htm EX-31.1 17567
3 ex31-2.htm EX-31.2 17472
4 ex32-1.htm EX-32.1 8268
  Complete submission text file 0001493152-25-001743.txt   3189024

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE vicp-20240331.xsd EX-101.SCH 24800
6 XBRL CALCULATION FILE vicp-20240331_cal.xml EX-101.CAL 26620
7 XBRL DEFINITION FILE vicp-20240331_def.xml EX-101.DEF 129120
8 XBRL LABEL FILE vicp-20240331_lab.xml EX-101.LAB 216334
9 XBRL PRESENTATION FILE vicp-20240331_pre.xml EX-101.PRE 179376
45 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 385443
Mailing Address 1735 BUFORD HIGHWAY STE. 215-113 CUMMING GA 30041
Business Address 1735 BUFORD HIGHWAY STE. 215-113 CUMMING GA 30041 470-514-4013
Vicapsys Life Sciences, Inc. (Filer) CIK: 0001468639 (see all company filings)

IRS No.: 621153426 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-56145 | Film No.: 25523593
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)